Larvol Delta - PESCO-Phase-2-Study-of-Pembrolizumab-DPXSurvivac-Vaccine-and-Cyclophosphamide-in-Advanced-Ovarian-Primary-Peritoneal-or-Fallopian-Tube-Cancer

maveropepimut-S (MVP-S) - IMV Inc

cyclophosphamide - Generic mfg.

Keytruda (pembrolizumab) - Merck (MSD)

http://clinicaltrials.gov/ct2/show/NCT03029403

Jun 18, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next